logo
The Bear Cloud Cirrus Pillows Help Me Sleep at Night, and They're 30% Off This Summer

The Bear Cloud Cirrus Pillows Help Me Sleep at Night, and They're 30% Off This Summer

CNET6 days ago
Summer sale: A pair of queen-size Bear Cloud Cirrus pillows is available for $105 -- a discount of 30% -- if you use code SUMMER on Bear's website. And the sale extends sitewide, so you can use the same code to get 30% off on mattresses, bed bases and sheets, too.
The pillows you use every night can have a huge impact on your quality of sleep. As a self-proclaimed poor sleeper (with the data to prove it), I've tried a ton of sleep products and accessories over the years to help me get better rest, including pillows.
As a combination sleeper, I switch positions constantly throughout the night, making it hard to find a pillow that's comfortable regardless of how weirdly I contort my body while sleeping. A few months ago, I swapped out our pillows (again) to try Bear's Cloud Cirrus Pillows and haven't looked back.
I love sleeping on Bear's fluffy Cloud Cirrus Pillows.
Aly Lopez/CNET
These pillows are incredibly fluffy and light. As soon as I rest my head on them, I feel like I'm floating away on a soft cloud. The material used inside is a 3D polyester fill, which is breathable and hypoallergenic -- a great feature for those with allergen sensitivities. I've also found that I sleep cooler on the Cloud Cirrus Pillows than others I've tried due to their light construction that allows for more airflow. To top it all off, they're also made cruelty-free thanks to the down-alternative materials.
Despite being soft and fluffy, they still offer plenty of support and help keep my neck and spine aligned no matter which position I'm sleeping in.
Bear offers free shipping, a lifetime warranty for mattresses and a 30-night return period for sleep accessories (including pillows) -- although with the cloudlike experience you'll have on the Bear Cloud Cirrus Pillows, I doubt you'll want to return them.
For more options, check out our roundup of the best pillow for every kind of sleeper.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Ellis George LLP: CA Court of Appeal Upholds $5 Million Jury Verdict Against Bristol-Meyers-Squibb-owned Impact Biomedicines
Ellis George LLP: CA Court of Appeal Upholds $5 Million Jury Verdict Against Bristol-Meyers-Squibb-owned Impact Biomedicines

Yahoo

time5 minutes ago

  • Yahoo

Ellis George LLP: CA Court of Appeal Upholds $5 Million Jury Verdict Against Bristol-Meyers-Squibb-owned Impact Biomedicines

Original verdict in Dr. James Brewer's fraud case reinstated by California Court of Appeal SAN DIEGO, July 21, 2025--(BUSINESS WIRE)--Ellis George LLP announced that The California Court of Appeal, Fourth Appellate District, has reversed a trial court order that reduced a jury verdict against Impact Biomedicines and instead reinstated the original $5,020,000 award. Impact Biomedicines, a division of Bristol-Meyers-Squibb, and Impact Biomedicine's founder and owner, Dr. John Hood, must pay San Diego physician and Alzheimer's researcher James Brewer M.D., Ph.D., more than $1 million in compensatory damages and $4 million in punitive damages in a fraudulent concealment case filed in 2019. Dr. Brewer, chair of the neurology department at UC San Diego, was represented by Christopher W. Arledge and Courtney L. Mitchell, both of Ellis George LLP, and Peter Afrasiabi of One LLP. At trial in the San Diego County Superior Court, a 12-member jury awarded Dr. Brewer more than $5 million, finding that Impact Biomedicines and Dr. Hood had defrauded Dr. Brewer as part of Impact Biomedicines' effort to end an FDA-mandated clinical hold and get Impact Biomedicines' experimental cancer drug approved. The jury accepted Dr. Brewer's argument that Impact Biomedicines and Dr. Hood had misled the FDA about the work Dr. Brewer had done for them and the conclusions he had reached and then concealed its false statements to the FDA from Dr. Brewer. Later, the trial court agreed that Dr. Brewer had proven his fraud case but reduced the damages number significantly. At the time, Mr. Arledge said he disagreed with the court's decision to reduce the damages and predicted that the trial court's order would be reversed on appeal. Today it was. According to the Court of Appeal's opinion, "We conclude that substantial evidence supports the jury's findings on liability and damages, and the jury's award of punitive damages was not constitutionally excessive…" "This was a hard-fought win against a very well-funded opponent and one of the largest, most-prestigious law firms in the country. Now a jury, a trial court, and an appellate court have all agreed that Dr. Brewer proved his fraud claim, and we're grateful to the Court of Appeal for recognizing that the trial court's reduction in Dr. Brewer's damages was a legal error," said Mr. Arledge. "This is an important win for Dr. Brewer and for patients who must be able to rely on the FDA drug-approval process." Impact Biomedicines was represented by Colleen C. Smith, John T. Ryan, Andrew R. Gray, and Melissa Arbus Sherry, all of Latham & Watkins. James Brewer v Impact Biomedicines, et al. Superior Court No. 37-2019-00067876-CU-CO-CTL About Ellis George LLP Ellis George LLP is an elite litigation and trial firm based in Los Angeles and with offices in San Francisco and New York. Whether plaintiff or defendant, individual, Fortune 500 corporation or entrepreneur, clients call upon Ellis George when seeking litigation counsel of the highest quality, creativity, dedication, and ethics. Visit View source version on Contacts Media Contact:Jim Goldman, GoldmanMediaGroup, for Ellis George LLPinfo@ 408-427-4349

Garmin Is Going Nuts with the Vivoactive 5, Now at a New All-Time Low on Amazon for No Reason
Garmin Is Going Nuts with the Vivoactive 5, Now at a New All-Time Low on Amazon for No Reason

Gizmodo

time7 minutes ago

  • Gizmodo

Garmin Is Going Nuts with the Vivoactive 5, Now at a New All-Time Low on Amazon for No Reason

Not everyone needs the new Garmin Fenix 8 at more than $1,000 to track its sporting progress. In fact, for 99% of us, the Garmin Vivoactive 5 is more than adequate. The watch is the perfect middle ground and delivers an excellent balance of performance, features and cost. No surprise, it's also a best-seller for those looking for a great fitness companion. Right now, you can purchase the Garmin Vivoactive 5 on Amazon for just $189, a staggering 37% off of its regular $299 price. This is the lowest price ever offered on this model, beating even past holiday discounts. If you're looking to upgrade or buy your very first fitness smartwatch, there's never been a better time to do so. See at Amazon The Vivoactive 5 brings together advanced health tracking and smart features in a lightweight and very elegant design. At the heart of the watch is its vibrant AMOLED display which delivers bright colors and sharp contrasts even under direct sunlight. With a battery life of up to 11 days in smartwatch mode, you'll spend less time charging and more time focused on training, recovery and day-to-day activities. What's more, the great Body Battery energy tracking offers you is a definite idea of how ready your body is by measuring the extent to which you are loaded or depleted. It takes into account your nap time, sleep quality, stress level and previous activity to customize information during your day. It's a powerful way to find out how your daily decisions are affecting your body and how to optimize your training or rest accordingly. If you want in-depth sleep tracking, the Vivoactive 5 includes advanced sleep analysis, and provides a sleep score and offering highly personalized sleep guidance. You'll get realistic, actionable guidance for improving your rest based on real facts, like your heart rate variability status. That is to say that your future health decisions are made with more than conjecture. Garmin creates watches that promote movement and the Vivoactive 5 is no different with over 30 integrated indoor and GPS sport apps. From running and cycling to HIIT, swimming, and even golf, there's a mode for all forms of movement. Wheelchair users were not left behind: a specific wheelchair mode monitors pushes rather than steps and includes special workouts and challenges. Automatic nap detection tracks naps and indicates how power naps influence your total energy, providing more information to assist in refining your routine. Health and wellness tracking extends far beyond the fundamentals as well. The Vivoactive 5 monitors your heart rate through your wrist, offers a daily morning report, estimates your fitness age and does menstrual and pregnancy tracking as well as stress tracking and meditation routines. If you're interested in pushing your fitness limits, the watch has high-end training features. The workout benefit feature tells you how each muscle-burning session will impact your body, and the recovery time guidance tells you how long you'll have to rest before you head out for your next session. You have the option to select preloaded workouts that vary from cardio, yoga, strength, HIIT, and Pilates, create your own using the Garmin Connect smartphone app. This deal is hard to pass up, so look for getting yours at this all-time low price. See at Amazon

F.D.A. Panel Debates ‘Black Box' Warning for Antidepressants in Pregnancy
F.D.A. Panel Debates ‘Black Box' Warning for Antidepressants in Pregnancy

New York Times

time8 minutes ago

  • New York Times

F.D.A. Panel Debates ‘Black Box' Warning for Antidepressants in Pregnancy

Over nearly four decades since Prozac was approved for the treatment of depression, waves of concern about the effects of antidepressants during pregnancy have resulted in a practical consensus: Though use of the drugs may be associated with a slight rise in the odds of birth defects, the risk of leaving a mother's depression untreated is often greater. But a high-level shift is taking place within the Department of Health and Human Services under Secretary Robert F. Kennedy Jr., who has made reducing the prescription of psychotropic drugs a policy priority. Among the select group of experts convened by the Food and Drug Administration on Monday to discuss the safety of antidepressants during pregnancy, around half said that women should receive a more clear and forceful warning about potential risks to the fetus. Andrew Nixon, an H.H.S. spokesman, said the agency would not comment on whether there were plans to require a so-called black box warning about the use of selective serotonin reuptake inhibitors, or S.S.R.I.s, in pregnancy. In his introductory remarks, F.D.A. commissioner Dr. Marty Makary said that 'some women are not aware' of the risks of taking antidepressants in pregnancy, suggesting openness to the idea. Around 5 percent of pregnant American women take antidepressants, he said. 'Serotonin might play a crucial role in the development of organs of a baby in utero,' Dr. Makary said. Want all of The Times? Subscribe.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store